文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Traditional Chinese Medicine: A promising strategy to regulate inflammation, intestinal disorders and impaired immune function due to sepsis.

作者信息

Wang Xu-Hua, Xu Ding-Qiao, Chen Yan-Yan, Yue Shi-Jun, Fu Rui-Jia, Huang Lu, Tang Yu-Ping

机构信息

Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research, Shaanxi University of Chinese Medicine, Xi'an, China.

出版信息

Front Pharmacol. 2022 Sep 16;13:952938. doi: 10.3389/fphar.2022.952938. eCollection 2022.


DOI:10.3389/fphar.2022.952938
PMID:36188532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9523403/
Abstract

Sepsis is described as a dysregulation of the immune response to infection, which leads to life-threatening organ dysfunction. The interaction between intestinal microbiota and sepsis can't be ignored. Furthermore, the intestinal microbiota may regulate the progress of sepsis and attenuate organ damage. Thus, maintaining or restoring microbiota may be a new way to treat sepsis. Traditional Chinese medicine (TCM) assumes a significant part in the treatment of sepsis through multi-component, multi-pathway, and multi-targeting abilities. Moreover, TCM can prevent the progress of sepsis and improve the prognosis of patients with sepsis by improving the imbalance of intestinal microbiota, improving immunity and reducing the damage to the intestinal barrier. This paper expounds the interaction between intestinal microbiota and sepsis, then reviews the current research on the treatment of sepsis with TCM, to provide a theoretical basis for its clinical application.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf8/9523403/cbe899b1cba1/fphar-13-952938-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf8/9523403/55e4180661f1/fphar-13-952938-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf8/9523403/6b0a7ca852fb/fphar-13-952938-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf8/9523403/45e5d65b76a7/fphar-13-952938-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf8/9523403/cbe899b1cba1/fphar-13-952938-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf8/9523403/55e4180661f1/fphar-13-952938-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf8/9523403/6b0a7ca852fb/fphar-13-952938-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf8/9523403/45e5d65b76a7/fphar-13-952938-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bf8/9523403/cbe899b1cba1/fphar-13-952938-g004.jpg

相似文献

[1]
Traditional Chinese Medicine: A promising strategy to regulate inflammation, intestinal disorders and impaired immune function due to sepsis.

Front Pharmacol. 2022-9-16

[2]
Traditional Chinese Medicine: A promising strategy to regulate the imbalance of bacterial flora, impaired intestinal barrier and immune function attributed to ulcerative colitis through intestinal microecology.

J Ethnopharmacol. 2024-1-10

[3]
An overview of traditional Chinese medicine affecting gut microbiota in obesity.

Front Endocrinol (Lausanne). 2023

[4]
Intestinal Escherichia coli and related dysfunction as potential targets of Traditional Chinese Medicine for respiratory infectious diseases.

J Ethnopharmacol. 2023-9-15

[5]
Review of the correlation between Chinese medicine and intestinal microbiota on the efficacy of diabetes mellitus.

Front Endocrinol (Lausanne). 2022

[6]
Research progress of traditional Chinese medicine on the treatment of diarrhea by regulating intestinal microbiota and its metabolites based on renal-intestinal axis.

Front Cell Infect Microbiol. 2024

[7]
[Research progress on the correlation between intestinal microecology and sepsis].

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024-8

[8]
Repairing gut barrier by traditional Chinese medicine: roles of gut microbiota.

Front Cell Infect Microbiol. 2024

[9]
Gut microbiota modulation and anti-inflammatory properties of Xuanbai Chengqi decoction in septic rats.

J Ethnopharmacol. 2021-3-1

[10]
The interactions between traditional Chinese medicine and gut microbiota in cancers: Current status and future perspectives.

Pharmacol Res. 2024-5

引用本文的文献

[1]
Clinical efficacy and mechanistic insights of Xuebijing in hand, foot, and mouth disease: a meta-analysis with integrated pharmacological approaches.

Ann Med Surg (Lond). 2025-5-20

[2]
Association Between Traditional Chinese Medicine Use and Sepsis Risk and Glucocorticoid Exposure in Patients With Systemic Lupus Erythematosus: A Retrospective Cohort Study.

Int J Rheum Dis. 2025-8

[3]
A Prospective Observational Study on the Effects of Decoction on Gut Microbiota and Clinical Outcomes in Sepsis Patients with Acute Gastrointestinal Injury.

Infect Drug Resist. 2025-7-11

[4]
Intestinal injury signaling pathway in sepsis.

Front Immunol. 2025-6-27

[5]
Investigating the Therapeutic Mechanisms of Honeysuckle (China) in Sepsis Through Network Pharmacology and Experimental Validation.

Infect Drug Resist. 2025-7-3

[6]
Xijiao Dihuang Decoction for Sepsis-Induced Acute Lung Injury: Network Pharmacology and Molecular Dynamics Insights.

J Inflamm Res. 2025-4-26

[7]
The emerging role of intestinal stem cells in ulcerative colitis.

Front Med (Lausanne). 2025-3-25

[8]
The Effect of Fuzheng Yiai Decoction on the Transdifferentiation of Lung Adenocarcinoma in EGFR-TKI-Resistant Mice.

Can Respir J. 2024-12-19

[9]
Pharmacology, medical uses, and clinical translational challenges of Saikosaponin A: A review.

Heliyon. 2024-11-15

[10]
Comparative pharmacokinetic study of Anisodamine Hydrobromide tablets and injection in septic acute lung injury rats.

Bioanalysis. 2024

本文引用的文献

[1]
Landscape of DILI-related adverse drug reaction in China Mainland.

Acta Pharm Sin B. 2022-12

[2]
Reduning Attenuates LPS-Induced Human Unmilical Vein Endothelial Cells (HUVECs) Apoptosis Through PI3K-AKT Signaling Pathway.

Front Pharmacol. 2022-7-12

[3]
Progress in the treatment of drug-induced liver injury with natural products.

Pharmacol Res. 2022-9

[4]
Alleviates Sepsis-Induced Acute Kidney Injury by Reducing Inflammation in Rats.

Evid Based Complement Alternat Med. 2022-5-21

[5]
Emodin Ameliorates Intestinal Dysfunction by Maintaining Intestinal Barrier Integrity and Modulating the Microbiota in Septic Mice.

Mediators Inflamm. 2022

[6]
Glycyrrhizin alleviates sepsis-induced acute respiratory distress syndrome via suppressing of HMGB1/TLR9 pathways and neutrophils extracellular traps formation.

Int Immunopharmacol. 2022-7

[7]
The pathogens of secondary infection in septic patients share a similar genotype to those that predominate in the gut.

Crit Care. 2022-3-24

[8]
The anti-inflammatory effects of cinnamyl alcohol on sepsis-induced mice via the NLRP3 inflammasome pathway.

Ann Transl Med. 2022-1

[9]
Protective role of crocin against sepsis-induced injury in the liver, kidney and lungs via inhibition of p38 MAPK/NF-κB and Bax/Bcl-2 signalling pathways.

Pharm Biol. 2022-12

[10]
The Effect of Shionone on Sepsis-Induced Acute Lung Injury by the ECM1/STAT5/NF-κB Pathway.

Front Pharmacol. 2022-1-26

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索